SCHEMBL22492006

SCHEMBL22492006

O=C1CCCC(Br)=C1c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HTT P42858 1/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
CYP2A6 P11509 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
BRD4 O60885 1/20 0.39
LMNA P02545 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CYP1A2 P05177 1/20 0.37
F3 P13726 1/20 0.37
HSD11B1 P28845 1/20 0.37
CACNA1D Q01668 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10281191 0.88 PTGS1 (0.46) KMT2AALDH1A1HTTPTGS1PTGS2
SCHEMBL979579 0.79 PTGS2 (0.54) KMT2AALDH1A1L3MBTL1HTTPTGS1
SCHEMBL22679771 0.76 BRD4 (0.46) KMT2AALDH1A1L3MBTL1HTTPTGS1
SCHEMBL8384573 0.76 KMT2A (0.40) KMT2AALDH1A1L3MBTL1HTTPTGS1
SCHEMBL22492035 0.76 SMN1; SMN2 (0.46) KMT2AALDH1A1L3MBTL1HTTPTGS1
SCHEMBL16432459 0.73 ALDH1A1 (0.42) KMT2AALDH1A1L3MBTL1HTTPTGS1
SCHEMBL28795587 0.72 PTGS2 (0.44) KMT2AALDH1A1L3MBTL1HTTPTGS1
SCHEMBL8517494 0.72 PTGS1 (0.40) KMT2AALDH1A1L3MBTL1HTTPTGS1
SCHEMBL29280849 0.72 PTGS2 (0.44) KMT2AALDH1A1L3MBTL1HTTPTGS1
Biphenyl SCHEMBL27725627 0.71 ALDH1A1 (0.50) KMT2AALDH1A1L3MBTL1HTTCYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11332472-B2 Substituted piperidines as inhibitors of ubiquitin specific protease 7 LES LABORATOIRES SERVIER (FR) 2022-05-17 US disclosed
US-20200407363-A1 NEW PIPERIDINYL DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 LES LABORATOIRES SERVIER (FR) 2020-12-31 US disclosed
EP-3717482-A1 NEW PIPERIDINYL DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 Les Laboratoires Servier SAS (FR) 2020-10-07 EP disclosed
CN-111542524-A Novel piperidinyl derivatives as inhibitors of ubiquitin-specific protease 7 法国施维雅药厂 2020-08-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11332472-B2 Substituted piperidines as inhibitors of ubiquitin specific protease 7 USP7, PSMA7, PSMB7 KMT2A 815/4885ALDH1A1 1391/4885L3MBTL1 785/4885
US-20200407363-A1 NEW PIPERIDINYL DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 PSMB7, PSMA7, USP7 KMT2A 1046/4885ALDH1A1 1589/4885L3MBTL1 934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.